The FDA is expected to decide on treatments for COPD, psoriasis, rare neuroendocrine tumors, and a next-generation COVID-19 vaccine.

Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment.

It's that time of year when flu vaccines are becoming available in Australia. You may have received an email from your GP ...

Five years since the World Health Organization declared Covid-19 a global pandemic, Europe is still taking stock of what's changed and what hasn't. T ...